ARTICLE | Company News
Adventrx, Theragenex deal
October 30, 2006 8:00 AM UTC
ANX granted Theragenex exclusive U.S. rights to ANX-211 chitosan gel for use in viral-mediated diseases including the common cold, influenza and other respiratory tract infections. ANX will receive $...